EuroIntervention’s Post

https://lnkd.in/e8M_jyg3 Percutaneous treatments for pulmonary embolism (PE) are emerging as alternatives to conventional therapies with recent data, and safety profiles endorsing a shift towards a “primary percutaneous pulmonary intervention” strategy, similar to that for ST-elevation myocardial infarction. In this Eurointervention's state of the art we provide a comprehensive overview of percutaneous management options for PE, with a specific emphasis on catheter-directed treatments and their effect on patient out- comes. 

#TCT2024: Large-bore mechanical thrombectomy vs catheter-directed thrombolysis for treatment of intermediate-risk pulmonary embolism What do you think would be the future of catheter-directed treatment in patients with acute intermediate-risk PE? Do you think LBMT is better than CDT for its treatment? Read this review by Elad Asher of the results of the PEERLESS trial, presented by Wissam A Jaber in Washington ➡ https://lnkd.in/duVHF_eQ #interventionalcardiology #pulmonaryembolism #clinicaltrials

What is obstruction in Hypertrophic Cardiomyopathy, and what are the important considerations for patients in terms of management of the condition? Brand new video resource from Cardiomyopathy UK looking into considerations around septal reduction therapies as well as the potential impact of cardiac myosin inhibitors such as #mavacamten 📢 Watch here: https://lnkd.in/gHAYeTtG 📢

This is a tremendous result for  the real deal single shot approach in my experience . If Pulsar-Af results the same, we may just have the true “gold” standard.  Critical here is many studies presented today accepted primary endpoints to include being on Antiarrhythmic medication. IMHO this is a problematic approach which obfuscates the data. Not here. The real McCoy. 

In patients with aortic stenosis, higher plasma lipoprotein(a) concentrations were associated with faster rates of hemodynamic progression. https://ja.ma/3BHqcuH

In the world of medical treatments for musculoskeletal problems—from chronic pain and degenerative diseases to acute injuries—Regenerative Injection Therapies (RIT) are gaining momentum as a compelling alternative to more invasive procedures. This innovative approach includes methods such as Prolotherapy, Platelet-Rich Plasma (PRP), and the use of Structural Tissue Products, aiming to harness the body’s own healing capabilities to repair and strengthen damaged tissues. Want to learn more about Regenerative Injection Therapies? Check out our latest blog post here: https://lnkd.in/eKVmE4H4

📢The #Myoglobin Test Cassette is a diagnostic tool designed for the quantitative determination of Myoglobin in whole blood, serum, or plasma. It is used as an aid in the diagnosis of Myocardial Infarction (#MI). The test measures the level of Myoglobin, a protein released into the bloodstream during cardiac muscle damage. By accurately quantifying Myoglobin levels, the test assists healthcare professionals in diagnosing MI and assessing the severity of the condition. The test result is calculated using a Fluorescence Immunoassay Analyzer, which ensures precise and reliable measurements. This enables timely intervention and appropriate treatment strategies for patients suspected of having a #heart attack. The Myoglobin Test Cassette plays a crucial role in early detection and management of MI, contributing to improved patient outcomes.   🔎Learn more: https://lnkd.in/gRSk76t8 #hearthealth #health #MI #Myoglobin #detction #diagnosis #medicaldevices #AllTest #fluorescence

EIJ DEBATES Over time, the role of "ischaemia" and "viability" in determining who should undergo percutaneous coronary intervention (PCI) has been widely studied. Ischaemia, a condition of inadequate blood supply to the heart, and the concept of a hibernating myocardium indicating heart muscle viability, have historically guided PCI decisions. Recent findings from randomized trials, however, have questioned the effectiveness of these tests for PCI guidance, creating uncertainty about their current relevance in clinical decision-making, possibly limiting their use to specific cases or patients. https://ow.ly/cHKq50R4uur

CX 2024 welcomes a revolutionised Carotid and Acute Stroke programme (Wednesday 24 April) which, for the first time, expands upon carotid indications, new technologies and neurointeventions. Take a look at the series of upcoming debates below! 🆕 Domenico Valenti 🗣️ Debate: Patients with symptomatic near occlusion in the internal carotid artery (ICA) should only be treated medically Konstantinos Antonopoulos Rantner Barbara, MD, PhD, FEBVS 🗣️ Debate: Best medical treatment (BMT) only is as effective as carotid endarterectomy (CEA) or carotid artery stenting (CAS) in patients with symptomatic internal carotid artery (ICA) stenosis Melina De Vega De Ceniga 🗣️ Debate: Patients with symptomatic carotid artery web should only be treated medically Maarit Venermo 🗣️ Debate: CAS is the treatment of choice for underlying ICA stenosis after mechanical thrombectomy 🗣️ Debate: Patients with vertebro-basilar ischaemia should be treated with endovascular intervention Levansri Makalanda ➡️ View the programme in full: https://lnkd.in/eBiwitAf

A new preoperative prediction model combining biochemical indicators, conventional #ultrasound, and #CEUS can accurately identify microvascular invasion (MVI) in patients with single HCC ≤ 5cm, showing high accuracy and strong clinical benefit, which can help in decision-making regarding treatment. (Dan Lu et al.) #InsightsIntoImaging 🔗 https://buff.ly/3Z3KnMS